In 10 out of the 20 tested cancers (BLCA, BRCA, COAD, HNSC, LGG, LUAD, PAAD, PRAD, STAD, and UCEC), there were significantly more TP53 LOF or missense mutations in chromoanagenesis than in non-chromoanagenesis. Here, TP53 is linked to cancer.